Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Huntington Bancshares Incorporated (HBAN) vs Stryker Corporation (SYK) Price & Performance

Huntington Bancshares IncorporatedTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Huntington Bancshares Incorporated vs Stryker Corporation — how do they compare? Huntington Bancshares Incorporated trades at $15.32 (market cap $31.04B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 3.4× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (4.04%). Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Stryker Corporation for 21 Days on average.

HBANSYK
Market Cap
$31.04B$106.24B
Volume
23,864,1722,982,001
Sector
FinancialsHealth
52-Week High
$19.27$388.35
52-Week Low
$15.02$269.75
Typical Hold Time
52 Days21 Days
Enterprise Value
$49.57B$117.70B
Dividend Yield
4.04%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Huntington Bancshares Incorporated

Huntington Bancshares (HBAN) trades at $15.37, up 1.32% on the day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, missing in Q4 2025 and Q2 2026 but beating in Q1 2026, with Q3 2026 results pending. Revenue grew to $8.13B in 2025, and the stock trades at a P/E of 11.82, below the industry average. Recent news highlights increased call option activity and a dividend declaration of $0.16 payable in October 2026.

HBAN offers value with a low P/E and strong net income margin of 24.77%, but faces headwinds from interest rate pressures and reduced 2027 earnings guidance. Analyst consensus is a Buy with a $19.60 price target, implying 27% upside, though technical indicators and recent institutional put buying suggest near-term caution. Key risks include margin compression and competitive lending pressures.

Stryker Corporation

Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.

Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Huntington Bancshares Incorporated

Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.

Read more on HBAN →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →